Last reviewed · How we verify
mFOLFOX6 regimen — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
mFOLFOX6 regimen (mFOLFOX6 regimen) — Revolution Medicines, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| mFOLFOX6 regimen TARGET | mFOLFOX6 regimen | Revolution Medicines, Inc. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- mFOLFOX6 regimen CI watch — RSS
- mFOLFOX6 regimen CI watch — Atom
- mFOLFOX6 regimen CI watch — JSON
- mFOLFOX6 regimen alone — RSS
Cite this brief
Drug Landscape (2026). mFOLFOX6 regimen — Competitive Intelligence Brief. https://druglandscape.com/ci/mfolfox6-regimen. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab